論文種別 原著(症例報告除く)
言語種別 英語
査読の有無 その他(不明)
表題 Cryoballoon vs radiofrequency ablation in persistent atrial fibrillation: the CRRF-PeAF trial.
掲載誌名 正式名:European heart journal
略  称:Eur Heart J
ISSNコード:15229645/0195668X
掲載区分国外
巻・号・頁 pp.Online ahead of print
著者・共著者 Koji Miyamoto, Koshiro Kanaoka, Kenji Yodogawa, Yuhi Fujimoto, Hiroshi Fukunaga, So Asano, Takahiko Nagase, Muryo Terasawa, Takahiro Kusume, Yasuyuki Takada, Ken Takarada, Yuichiro Sagawa, Takatoshi Shigeta, Junichi Ooka, Masahiro Ishikura, Masue Yoh, Hiroki Takahashi, Yuko Inoue, Satoshi Nagase, Takeshi Aiba, Naoya Kataoka, Masahiko Takagi, Shintaro Yamagami, Suguru Nishiuchi, Yasuhiro Sasaki, Atsushi Kobori, Yasuteru Yamauchi, Yoshinao Yazaki, Kazuhiro Satomi, Junichi Nitta, Shingo Mizuno, Masato Murakami, Keiichi Ashikaga, Jun Kishihara, Hidehira Fukaya, Yu-Ki Iwasaki, Wataru Shimizu, Kengo Kusano
発行年月 2025/07
概要 BACKGROUND AND AIMS:There are limited prospective data on the efficacy, safety, and impact on reverse remodelling of cryoballoon ablation as compared to radiofrequency ablation for persistent atrial fibrillation.METHODS:A prospective, multicentre, randomized, non-inferiority clinical trial was conducted to compare the efficacy and safety of cryoballoon vs radiofrequency ablation for persistent atrial fibrillation. A total of 500 patients with persistent atrial fibrillation were randomized across 12 centres. The primary endpoint was the occurrence of atrial tachyarrhythmias at 1 year with a 90-day blanking period after ablation.RESULTS:The final analysis included 499 patients, with a median age of 69 years (interquartile range, 61-74); 249 patients were allocated to the cryoballoon group, and 250 to the radiofrequency group. In the intention-to-treat analysis, the primary endpoint was observed in 56 patients (22.5%) in the cryoballoon group and 58 (23.2%) in the radiofrequency group, and the cryoballoon group demonstrated non-inferiority compared to the radiofrequency group for the primary endpoint (hazard ratio .99; 95% confidence interval, .69-1.43; P = .96). The radiofrequency group showed a greater reduction in left atrial size (left atrial volume index) at 1 year than the cryoballoon group [-11 mL/m2 (interquartile range, -19 to -4) vs -4 mL/m2 (interquartile range, -13 to 3), P < .001].CONCLUSIONS:In this randomized trial, cryoballoon ablation was non-inferior to radiofrequency ablation for the occurrence of atrial tachyarrhythmias at 1 year in patients with persistent atrial fibrillation.
DOI 10.1093/eurheartj/ehaf451
PMID 40704730